Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07018895Completed
Randomised, single-blind trial (2 arms), sponsored by Tomsk National Research Medical Centre of the Russian Academy of Sciences. Primary endpoint: Incidence of intolerance to IHHT sessions. Started Jul 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07018895.